PF-06952229, CAS [[1801333-55-0]]

Artikelnummer: MCE-HY-136244
Artikelname: PF-06952229, CAS [[1801333-55-0]]
Artikelnummer: MCE-HY-136244
Hersteller Artikelnummer: HY-136244
Alternativnummer: MCE-HY-136244-100MG,MCE-HY-136244-50MG,MCE-HY-136244-10MG,MCE-HY-136244-10MMX1ML,MCE-HY-136244-5MG,MCE-HY-136244-25MG
Hersteller: MedchemExpress
Kategorie: Biochemikalien
PF-06952229 is a potent, selective and orally active TGFbR1 inhibitor. PF-06952229 specifically binds to TGFbR1 and prevents TGFbR1-mediated signal transduction. PF-06952229 is a promising antineoplastic agent for the study solid tumors, especifically metastatic breast cancer[1].
Molekulargewicht: 458.91
Reinheit: 99.92
CAS Nummer: [1801333-55-0]
Formel: C23H24ClFN4O3
Target-Kategorie: TGF-beta Receptor
Anwendungsbeschreibung: MCE Product type: Reference compound